The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey
Open accessAbstract
Objective: To determine the global capacity (availability, accessibility, quality, and affordability) to deliver kidney replacement therapy (dialysis and transplantation) and conservative kidney management. Design: International cross sectional survey. Setting: International Society of Nephrology (ISN) survey of 182 countries from July to September 2018. Participants: Key stakeholders identified by ISN’s national and regional leaders. Main outcome measures: Markers of national capacity to deliver core components of kidney replacement therapy and conservative kidney management. Results: Responses were received from 160 (87.9%) of 182 countries, comprising 97.8% (7338.5 million of 7501.3 million) of the world’s population. A wide variation was found in capacity and structures for kidney replacement therapy and conservative kidney management—namely, funding mechanisms, health workforce, service delivery, and available technologies. Information on the prevalence of treated end stage kidney disease was available in 91 (42%) of 218 countries worldwide. Estimates varied more than 800-fold from 4 to 3392 per million population. Rwanda was the only low income country to report data on the prevalence of treated disease; 5 (<10%) of 53 African countries reported these data. Of 159 countries, 102 (64%) provided public funding for kidney replacement therapy. Sixty eight (43%) of 159 countries charged no fees at the point of care delivery and 34 (21%) made some charge. Haemodialysis was reported as available in 156 (100%) of 156 countries, peritoneal dialysis in 119 (76%) of 156 countries, and kidney transplantation in 114 (74%) of 155 countries. Dialysis and kidney transplantation were available to more than 50% of patients in only 108 (70%) and 45 (29%) of 154 countries that offered these services, respectively. Conservative kidney management was available in 124 (81%) of 154 countries. Worldwide, the median number of nephrologists was 9.96 per million population, which varied with income level. Conclusions: These comprehensive data show the capacity of countries (including low income countries) to provide optimal care for patients with end stage kidney disease. They demonstrate substantial variability in the burden of such disease and capacity for kidney replacement therapy and conservative kidney management, which have implications for policy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eysenbach, G. (2004) · Journal of Medical Internet Research · doi:10.2196/jmir.6.3.e34 · Cited by 6,480
Worldwide access to treatment for end-stage kidney disease: a systematic review
Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H. M., Okpechi, I., Zhao, M.-H., Lv, J., Garg, A. X., Knight, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61601-9 · Cited by 2,339
Self-citationChronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213
Levey, A. S., & Coresh, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60178-5 · Cited by 1,841
Guidelines for accurate and transparent health estimates reporting: the GATHER statement
Stevens, G. A., Alkema, L., Black, R. E., Boerma, J. T., Collins, G. S., Ezzati, M., Grove, J. T., Hogan, D. R., Hogan, M. C., Horton, R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30388-9 · Cited by 1,798
Xie, Y., Bowe, B., Mokdad, A. H., Xian, H., Yan, Y., Li, T., Maddukuri, G., Tsai, C.-Y., Floyd, T., & Al-Aly, Z. (2018) · Kidney International · doi:10.1016/j.kint.2018.04.011 · Cited by 1,391
Article Commentary: Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs)
Weldring, T., & Smith, S. M. S. (2013) · Health Services Insights · doi:10.4137/hsi.s11093 · Cited by 1,104
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Levin, A., Tonelli, M., Bonventre, J., Coresh, J., Donner, J.-A., Fogo, A. B., Fox, C. S., Gansevoort, R. T., Heerspink, H. J. L., Jardine, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30788-2 · Cited by 919
Self-citationDavison, S. N., Levin, A., Moss, A. H., Jha, V., Brown, E. A., Brennan, F., Murtagh, F. E. M., Naicker, S., Germain, M. J., O'Donoghue, D. J., et al. (2015) · Kidney International · doi:10.1038/ki.2015.110 · Cited by 580
Self-citationAssessment of Global Kidney Health Care Status
Bello, A. K., Levin, A., Tonelli, M., Okpechi, I. G., Feehally, J., Harris, D., Jindal, K., Salako, B. L., Rateb, A., Osman, M. A., et al. (2017) · JAMA · doi:10.1001/jama.2017.4046 · Cited by 487
Self-citationHealth Economic Evaluations: The Special Case of End-Stage Renal Disease Treatment
Winkelmayer, W. C., Weinstein, M. C., Mittleman, M. A., Glynn, R. J., & Pliskin, J. S. (2002) · Medical Decision Making · doi:10.1177/027298902236927 · Cited by 341
Purnell, T. S., Luo, X., Cooper, L. A., Massie, A. B., Kucirka, L. M., Henderson, M. L., Gordon, E. J., Crews, D. C., Boulware, L. E., & Segev, D. L. (2018) · JAMA · doi:10.1001/jama.2017.19152 · Cited by 309
Global Cardiovascular and Renal Outcomes of Reduced GFR
Thomas, B., Matsushita, K., Abate, K. H., Al-Aly, Z., Ärnlöv, J., Asayama, K., Atkins, R., Badawi, A., Ballew, S. H., Banerjee, A., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016050562 · Cited by 266
Self-citationEconomic evaluation of dialysis therapies
Klarenbach, S. W., Tonelli, M., Chui, B., & Manns, B. J. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.145 · Cited by 260
Self-citationMaintenance Dialysis throughout the World in Years 1990 and 2010
Thomas, B., Wulf, S., Bikbov, B., Perico, N., Cortinovis, M., Courville de Vaccaro, K., Flaxman, A., Peterson, H., Delossantos, A., Haring, D., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014101017 · Cited by 205
Pisoni, R. L., Zepel, L., Fluck, R., Lok, C. E., Kawanishi, H., Süleymanlar, G., Wasse, H., Tentori, F., Zee, J., Li, Y., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.09.012 · Cited by 185
Global Cardiovascular and Renal Outcomes of Reduced GFR
Thomas, B., Matsushita, K., Abate, K. H., Al‐Aly, Z., al., E., Asayama, K., Atkins, R., Badawi, A. F., Ballew, S. H., Banerjee, A., et al. (2017) · UCL Discovery (University College London) · Cited by 181
Self-citationIncreasing access to integrated ESKD care as part of universal health coverage
Harris, D. C. H., Davies, S. J., Finkelstein, F. O., Jha, V., Donner, J.-A., Abraham, G., Bello, A. K., Caskey, F. J., Garcia, G. G., Harden, P., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.12.005 · Cited by 169
Self-citation1990-2010 Global Cardiovascular Disease Atlas
Moran, A. E., Roth, G. A., Narula, J., & Mensah, G. A. (2014) · Global Heart · doi:10.1016/j.gheart.2014.03.1220 · Cited by 129
A global overview of renal registries: a systematic review
Liu, F. X., Rutherford, P. A., Smoyer‐Tomic, K. E., Prichard, S. S., & Laplante, S. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0028-2 · Cited by 107
Global Kidney Health Atlas (GKHA): design and methods
Bello, A. K., Johnson, D. W., Feehally, J., Harris, D. C. H., Jindal, K. K., Lunney, M., Okpechi, I. G., Salako, B. L., Wiebe, N., Ye, F., et al. (2017) · Kidney International Supplements · doi:10.1016/j.kisu.2017.08.001 · Cited by 80
Self-citationBurden, access, and disparities in kidney disease
Crews, D. C., Bello, A. K., Saadi, G., Li, P. K. T., García-García, G., Andreoli, S. P., Crews, D., Kalantar‐Zadeh, K., Kernahan, C., Kumaraswami, L. A., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.11.007 · Cited by 79
Self-citationShah, K. K., Murtagh, F. E., McGeechan, K., Crail, S., Burns, A. P., Tran, A. D., & Morton, R. L. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027776 · Cited by 57
Ethical issues in dialysis therapy
Jha, V., Martin, D., Bargman, J. M., Davies, S., Feehally, J., Finkelstein, F., Harris, D. C. H., Misra, M., Remuzzi, G., & Levin, A. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32408-4 · Cited by 50
Self-citationDisparities in worldwide treatment of kidney failure
Coresh, J., & Jafar, T. H. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61890-0 · Cited by 46
Carga, acceso y disparidades en enfermedad renal
Crews, D. C., Bello, A. K., & Saadi, G. E. (2019) · Revista Colombiana de Nefrología · doi:10.22265/acnef.6.1.341 · Cited by 42
Self-citationIdentification and Prioritization of Quality Indicators for Conservative Kidney Management
Harrison, T. G., Tam‐Tham, H., Hemmelgarn, B. R., James, M. T., Sinnarajah, A., & Thomas, C. M. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.08.014 · Cited by 37
Fuller, D. S., Bieber, B. A., Pisoni, R. L., Li, Y., Morgenstern, H., Akizawa, T., Jacobson, S. H., Locatelli, F., Port, F. K., & Robinson, B. M. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015060673 · Cited by 36
Worldwide Preparedness for Kidney Health Care
Mandayam, S. A., & Winkelmayer, W. C. (2017) · JAMA · doi:10.1001/jama.2017.2825 · Cited by 10
Cited by
Kalantar-Zadeh, K., Jafar, T. H., Nitsch, D., Neuen, B. L., & Perkovic, V. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00519-5 · Cited by 1,461
Self-citationChronic kidney disease and the global public health agenda: an international consensus
Francis, A., Harhay, M. N., Ong, A. C. M., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., Fliser, D., Roy-Chaudhury, P., Fontana, M., Nangaku, M., et al. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00820-6 · Cited by 1,374
Self-citationThe current and future landscape of dialysis
Himmelfarb, J., Vanholder, R., Mehrotra, R., & Tonelli, M. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0315-4 · Cited by 650
Self-citationEpidemiology of haemodialysis outcomes
Bello, A. K., Okpechi, I. G., Osman, M. A., Cho, Y., Htay, H., Jha, V., Wainstein, M., & Johnson, D. W. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00542-7 · Cited by 631
Self-citationBello, A. K., Okpechi, I. G., Levin, A., Ye, F., Damster, S., Arruebo, S., Donner, J.-A., Caskey, F. J., Cho, Y., Davids, M. R., et al. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00570-3 · Cited by 522
Self-citation
Metadata
- Authors
- Bello, A. K., Levin, A., Lunney, M., Osman, M. A., Ye, F., Ashuntantang, G. E., Bellorin-Font, E., Benghanem Gharbi, M., Davison, S. N., Ghnaimat, M., Harden, P., Htay, H., Jha, V., Kalantar-Zadeh, K., Kerr, P. G., Klarenbach, S., Kovesdy, C. P., Luyckx, V. A., Neuen, B. L., O’Donoghue, D., Ossareh, S., Perl, J., Rashid, H. U., Rondeau, E., See, E., Saad, S., Sola, L., Tchokhonelidze, I., Tesar, V., Tungsanga, K., Turan Kazancioglu, R., Wang, A. Y.-M., Wiebe, N., Yang, C.-W., Zemchenkov, A., Zhao, M.-H., Jager, K. J., Caskey, F., Perkovic, V., Jindal, K. K., Okpechi, I. G., Tonelli, M., Feehally, J., Harris, D. C., & Johnson, D. W.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2019-10-31
- Volume
- 367
- Pages
- l5873
- ISSN
- 1756-1833 (ISSN-L)
- 0959-8138
- OpenAlex
- W2982553809
- Cited by
- 280
- References
- 29
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.